Haemato Statements
HA
Haemato Income Statement
B
M
EUR (except Earnings per share)
Financial
Revenue
Cost of sales
Gross profit
Research and development
Selling, general and administrative
Total operating expenses
Operating income
Interest expense
Other income
Income before tax
Provision for income taxes
Net income
Diluted earnings per share
Shares outstanding after dilution
133.64
100
123.39
92.3
10.243
7.7
—
0
2.047
1.5
4.985
3.7
5.258
3.9
-1.478
-1.1
0.001
0.0007
3.781
2.8
1.5
1.1
2.281
1.7
0.44
5.184
127.17
100
117.68
92.5
9.486
7.5
—
0
2.128
1.7
5.578
4.4
3.908
3.1
4.537
3.6
—
0
8.445
6.6
1.116
0.9
7.33
5.8
1.402
5.228
120.97
100
108.85
90
12.121
10
—
0
2.814
2.3
7.734
6.4
4.387
3.6
-2.348
-1.9
—
0
2.039
1.7
1.176
1
0.863
0.7
0.165
5.23
133.52
100
119.87
89.8
13.643
10.2
—
0
3.689
2.8
9.712
7.3
3.931
2.9
-3.096
-2.3
—
0
0.835
0.6
1.339
1
-0.504
-0.4
-0.101
4.977
151.53
100
134.44
88.7
17.088
11.3
—
0
3.814
2.5
9.858
6.5
7.23
4.8
1.292
0.9
—
0
8.522
5.6
1.484
1
7.038
4.6
1.35
5.213
122.52
100
113.84
92.9
8.682
7.1
—
0
3.398
2.8
8.286
6.8
0.397
0.3
-2.356
-1.9
—
0
-1.96
-1.6
0.051
0.04
-2.011
-1.6
-0.829
2.426